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ABSTRACT
The 5' flanking regions of the mouse and pig urokinase
plasminogen activator (uPA) genes were sequenced
and sequence homology interrupted by repeat
elements was found to extend to - 4.6kb in pig and
- 6.6kb in mouse. A transient transfection procedure
was devised for the murine macrophage cell line
RAW264. Pig uPA promoter-CAT constructs were more
active than mouse constructs in this assay. This
contrast may involve sequence differences within 100
bp of the transcription start site. The selective deletion
of distal regions of the promoter (> 2.6 kb upstream),
and of a conserved element, 5'-AGGAGGAAATGAGG-
TCA-3' around - 2 kb greatly reduced the activity of
reporter constructs in RAW264 cells. Electrophoretic
mobility shift assays using the latter sequence
identified a single nuclear protein complex. This
element has been referred to as PEA3/AP1 -like, but the
complex did not comigrate with either AP1 or known
proteins that bind polypurines (including the
macrophage-specific factor PU-1) and was not
competed by AP1 or polypurine oligonucleotides. uPA
promoters contain multiple AP1 and AP2-like DNA
sequences, which were recognised by nuclear proteins
expressed constitutively in RAW264 cells. They also
contain multiple binding sites for NFxB but activated
NFxB was not expressed in RAW264 cells. The
conserved, transcribed 5' non-coding sequences were
also required for maximal gene expression. Hence, the
uPA promoter contains multiple weak cis-acting
elements distributed over 7.0 kb 5' to the translation
start site.
INTRODUCTION
Urokinase plasminogen activator (uPA) has been implicated in
extracellular proteolysis in numerous cellular systems especially
metastatic tumor cells and macrophages (reviewed in 1). The
EMBL accession no. X63356
genes encoding uPA, and some 5' flanking regions, have been
sequenced in pig (2, 3), human (4, 5), mouse (6) and chicken
(7). Sequence comparisons between mouse, human and pig genes
(6) revealed the unusual property that the introns were 50-70%
conserved between the three species, a level of conservation only
marginally less than that between the exons. In the published
sequences, there is an abrupt decline in homology in the
immediate 5' flanking region. Given the diversity of stimuli that
alter the expression ofuPA in various cell types, including growth
factors, oncogenes, cyclic AMP agonists glucocorticoids,
retinoids, phorbol esters and cycloheximide (8-14) it is rather
surprising to observe so little sequence identity in the region often
involved in transcriptional regulation. There are several possible
explanations which could account for this observation: (i) the gene
is regulated differently in different species, (ii) the control
segments lie within the introns or at the 3' end of the gene, (iii)
conserved control elements lie outside the previously published
5' sequence. In support of the third possibility, studies in pig
LLC-PKI cells have suggested that essential sequences involved
in transcriptional activation by calcitonin and cyclic AMP agonists
lie more than 3.5 kb upstream (14). In the human uPA 5' flanking
sequence, an enhancer element that activates transcription of an
enhancerless SV-40 promoter was identified between -2350 and
-1824 (4). More recently, R0rth et al. (9) reported the existence
of similar elements around -2.4 kb that conferred sensitivity
to epidermal growth factor and phorbol ester in mouse
keratinocytes. We have sequenced the pig uPA 5' flanking
sequence to -4.6 kb, and the mouse uPA flanking sequence to
-6.6 kb and have identified extensive sequence alignment outside
the previously known sequence.
The level of uPA mRNA and/or enzymic activity is increased
in macrophages by many stimuli, including the major growth and
differentiation factor, macrophage colony-stimulating factor
(CSF-1), phorbol esters and interferon gamma (15, 11; KS,
DAH; unpublished) and is reduced by others including
glucocorticoids and prostaglandins (11). Studies on transcriptional
regulation of gene expression in macrophages have been
* To whom correspondence should be addressed
k.) 1991 Oxford University Press
6840 Nucleic Acids Research, Vol. 19, No. 24
constrained by the difficulties in introducing DNA into the cells
for transient expression analysis, and few studies on the activity
of any promoter in macrophages have appeared. We have
developed an electroporation technique for transient transfection
of the murine macrophage cell line, RAW264 (16), which
expresses uPA mRNA (KS, DAH; unpublished). Transient
expression assays, using mouse and pig promoters fused to the
chloramphenicol acetyl transferase (CAT) gene, have been used
to compare the activity of the mouse and pig uPA promoters and
to identify regions that are involved in constitutive expression
of the uPA gene in these cells.
MATERIALS AND METHODS
Isolation and sequencing of genomic clones
Construction of a pig genomic DNA library in XEMBIA
bacteriophage and isolation of a uPA genomic clone, XYN4, have
been reported previously (3). The clone contains 7 kb of 5'
flanking region of the uPA gene. The sequence of 900 bp of 5'
flanking region, 6 kb of transcribed region and 300 bp of 3'
flanking region has been reported (3). In this work we extended
the sequencing up to the nearest EcoRI site from the transcription
initiation site (4.66 kb from the initiation site) using the chemical
digestion method of Maxam and Gilbert (17). DNA fragments
created using appropriate restriction sites were labelled either at
the 5' end with polynucleotide kinase and ['y-32P]ATP or at the
3' end with terminal transferase and [ci-32P]-ddATP. In most
cases the sequence was read on both strands.
Mouse genomic clones were obtained by screening a mouse
genomic library, using the longest Pst I fragment from a mouse
uPA cDNA clone pDB15 (3). To ensure that the clone contained
the 5' flanking region, these clones were further screened with
an Xba I-Xba I fragment of the pig uPA gene (-2695 to -1770).
As noted below, this probe subsequently proved to have regions
of 90% homology with the mouse gene. The genomic library
was provided by Shigeki Shibahara, and was constructed in
XEMBL4 using a Sau3A I partial digest of BALB/c mouse liver
DNA. The mouse sequence extending from the Bgl II site flanking
the known sequence at -2187 to the Xba I site at -6616 was
obtained by subcloning the DNA in both orientations into
pBluescript (Stratagene), preparing a series of defined restriction
enzyme-mediated deletions and performing dideoxy-sequencing
on double-stranded plasmid templates using a Pharmacia T7
polymerase sequencing kit. Some gaps were filled by preparing
defined oligonucleotide primers based on previously obtained
sequence.
Nuclear extracts
Nuclear extracts were prepared with a variation of the method
of Osbom et al. (18). Cells were washed with phosphate buffered
saline, centrifuged and resuspended in Dignam buffer A (19)
containing 0.1% Nonidet P40 (100 ml/107 cells) at 4°C. Nuclei
were gendy pelleted (250 xg, 10 min), and resuspended in Buffer
C. After 10mins on ice, the extracts were centrifuged at
10,00Oxg for 10min and the supernatant was removed and
diluted 5-fold in buffer D. The protein content of the extracts
was determined using a modified Bradford assay (BioRad), and
the extracts were stored frozen at -70°C.
Electrophoretic mobility shift assay (EMSA)
Oligonucleotide probes were labelled with a-[32p]-dATP using
DNA polymerase 1 (Klenow fragment) and a 10 bp primer
complementary to the 3' end of the full length oligonucleotide.
Binding reactions contained 2 Ag of nuclear extract protein, 1jig of poly d(IC), 0.5 ng of probe DNA, 10 mM EDTA and 5%
glycerol in a final volume of 6 1l of buffer D. After 30 min at
room temperature, samples were loaded onto polyacrylamide gels
(BioRad MiniProtean II) of the desired concentration, made up
in 50 mM Tris-380 mM glycine-2 mM EDTA pH 8.5. The gels
were run at constant voltage in the same buffer. Bromophenol
blue was added to one well (usually the probe control) and
electrophoresis stopped when the dye reached the end of the gel.
Gels were washed in 5% acetic acid, dried and autoradiographed.
The oligonucleotide probe sequences used were as follows:
PU1: 5'-CTGAAAGAGGAACTTGGTTAGGTA-3' (20) mB:
5'-GGCAAGGCTATTTGGGAAGGGAAAATA-3' (21) API:
5'-TTCCGGCTGACTCATCAAGCG-3' (22); supplied by
Promega xB: 5'-AGGGACTTTCCGCTGGGGACTi--CCA-3'
(18) PEA3/API: 5'-TCTCTGGCCAGGAGGAAATGAGGTC-
ATCTTGCTCT-3' (9) AP2-like: 5'-GAATCAGCATGACAG-
CCTCCAGCCAAGTAA-3' (-2410, mouse uPA, Fig. 2).
Apart from the commercial API oligonucleotide, all other probes
were prepared on a Milligen 7510 DNA Synthesiser within the
Centre for Molecular Biology and Biotechnology, University of
Queensland.
Preparation and transfection of plasmid constructs
In the plasmid pUPACAT the 5' flanking sequences of the mouse
uPA gene from the Xba I site at -6616 to the Sac I site at +8
was placed upstream of the chloramphenicol acetyl transferase
(CAT) reporter gene in pGeorge, a vector constructed from
pBR322, the CAT gene, and pUCl9 multiple cloning site. The
puPACAT2 construct was made by inserting mouse uPA
promoter sequences from -6616 to the Xba I site at +398
upstream of the CAT gene in pGeorge. pCAT4660 is a plasmid
containing 4660 bp of pig uPA 5' flanking region linked to the
CAT gene (23). pAPEA-3/AP1 CAT4660 was prepared using
the polymerase chain reaction, and is identical to pCAT4660
except that the sequence from -2007 to -1989, including the
PEA3 and API-like sequences, is replaced by AAT, creating a
convenient restriction site. The nucleotide G at -3530 was
changed to C in order to destroy the Xho 1 site.
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Figure 1. Pustell matrix plot. DNA sequences from the mouse and pig uPA
5'-flanking regions were compared using the Pultell matrix algorithm of the
MacVector 3.04 application on a Macintosh Ucx (25). The areas of strong sequence
similarity are indicated by regions A, B and C. The transcription start sites for
both genes are marked with arrows. Areas of repeat sequence are marked; BI,
B2 and R (polypurine).
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RAW264 tumour cells were grown in RPMI-1640 medium plus
5% foetal calf serum. The cells were harvested in logarithmic
growth phase, washed, and resuspended at ca. 2 x iO7/ml in
RPMI-1640 with 10% foetal calf serum and 20 mM Hepes, pH
7.1. Aliquots of 250 ,^d of cells were electroporated at room
temperature with 10-25 ptg of CsCl gradient purified plasmid
DNA in an 0.4 cm electroporation cuvette at 300 V, 960 AF using
a Bio-Rad Gene Pulser with a capacitance extender. The
concentration of DNA used in studies of deletion mutants was
adjusted so that each plasmid was present at the same molar
concentration. The cells were then returned to culture and after
2-3 days were harvested and assayed for CAT activity essentially
as described by Gorman et al. (24). Cell extract (10 to 200 ,tg
of protein, depending on the expected activity) was incubated
with 0.25 ACi of D-threo-[dichloroacetyl-1-14C]chloramphenicol
(Amersham) at 57 mCi/mmol and 2.2 mM acetyl-CoA in a
volume of 180 Al for 1 to 4 hours. The conversion of labelled
substrate to acetylated chloramphenicol was quantitated using an
AMBIS Radioanalyser. Conversion of chloramphenicol was kept
below 20% to minimise errors due to substrate depletion.
Conversions were corrected by the subtraction of results for
chloramphenicol incubated with untransfected control protein
extract. We chose not to cotransfect a control plasmid with the
reporter constructs for three reasons; (i) the variation in CAT
expression between replicates transfected with the same plasmid
was small, and no reference activity was needed to control for
such variation; (ii) the use of such controls assumes there is no
'cross-talk' between transfected promoters whereas we find that
the activity of one reporter construct can vary inversely with that
of a co-transfected construct because of competition for a limiting
factor; (iii) because we are dealing with a weak promoter,
especially in the truncated mouse constructs, we have to use
relatively high amounts of plasmid for transfection
(50- 125ug/ml). At this concentration, electroporation causes
DNA-dependent cellular cytotoxicity, and addition of more DNA
of any form (such as a second reporter construct) reduces both
CAT expression and cell viability.
Cell Culture
All cell culture reagents were obtained from either Cytosystems
(Sydney) or Commonwealth Serum Laboratories (Melbourne).
The cell line RAW264 was obtained from the American Type
M -2624 AAAGTCTAACACAGACTGCACCAAAAATAGAGATTTC-AGAGAG--TCTAAAGACTAACCAGGAGA-AAGGCAGTTCTGT
H -2153 AAAAAAAAAAGAACTGTGCACAAAGATTTCAGAGAGTGCTAAAG .--------.TTAGCGCATGGATAAGGAAGTTCTGT
P -2186 ACTGAAAGACTAGCACATACTGCACCGAA-AGACAC--- AGAGAGCACCAAAGAGCACAGAGTGGAAAGGAAGTTCTGT
*. 0.**a e.e ...e *. .ee.*.. - -
M -2548 GATGAGTTGGAGGCACGAGGATTGTTCATCCAGGTGAAG .------AAGTGGCGGTAGAAGGAGGAAGAGGGC---.-
H -2082 GAAGAGTTGAAG-TGCTAGG--------------TGAAGAGGTGGCA--CGGGGG-AGGAGGGGGCGGAAGGGGAGAAAG
P -2111 CTTCAC--AGAGACTGTAGGATTGTTCAACCAGGTGAAGAGGCCATAGGAGGAAGGAG-GGGG--AAGAGGGG ------
Se............. . so 50 00
PEA3V API
M -2482 --TATCACACTGCATAGCGGTCTC.----------.TGGCGGAGGAAATGAGGTCA T-TGCTCTCAAAGCAATKA(GCA
H -2020 GGTGTCACGCTTCATAACGGTCTCCAAACCTCTTTGTCCAGGAGGAAATGAAGTCATCTGTCCTCTCA--GCAATCAGCA
P -2043 --TGTCATGCTGTATAACGGTCTCCAAGCCTCTTTGTCCAAGAGGAAATGAGGTCATCC-TGCTCTCAA-G-AATCAGTA
e.e.e..ea..
.
..eeaeee*... ...ee e*.*S4' - *. e.eeeeee. e.eeeeee
AP2 AP1 API NFKB
M -2416 TGACAGCCTCCAGCCAAGTAATC - GAGTCAJGAGAGCTGTTGGGGGGGCCATrT-GA-ATGACAGCCTGCT GGAAT
H -1942 TGACAGCCTCCAGCCAAGTAACCCTGGAGTCATGAGAGCTGCTAGGGGAGCAACATGAATCATGACGGCCC-CTGGGAAT
P -1968 TGACAGCCTCCAGCCAAGTAATCT-GGAGTCATGAGAGCTGCTGGGGGAGCTC-GTGAATCAGAAGAGTCTGCTGGGAAA
EBI AP3 AP2
M -2337 TTC TAATAACTAAACTAG- AGTTTC GGGTAAATC TCAGGCTGT- AACACTCTGTTTACATTTTGATCACGTTTGTTT
H -1861 TTCCTGATAACTAACCTGGGAGTTTCGGGGTAAGTCCTCAGGCTGCAGCATCTCTGTTTATGTTCTGGTCACGTTTATTT
P -1890 TTCCTGATAACTAACCTAGGAGTTTCGGGGTAGGTCCTCAGGCTGT- ACATCTCTGTTTACATTCTGATCACGTTTATTT
*eeeeoeoe.eeeeeo .**e*****. e.e.......***. ce....... ...........
PU- 1
M -2258 ACAATTAGTGGCTTCTTAAACATAAACATAACTGGCCACAGTCTTCT[AAGGAA TAGCAA-GTTGCCTCTGAGATCTTA
H -1781 ACAATTAATGGGTTCTCAAATCCAAACAAAACTGACCACAGTCTTCTAGAGGAAGTAGCAAGGTTGGCTCTGAAGCCTAT
P -1811 ACAAGGAATGGGTT-TTAACTCCAAACAAAACATAG--CAGTCTTCTAGAGGAAGTAGAGGCCAAT-TCTGC--GCCICC
APi
M -2179 TGGAATCTC6GATTC-ATGGT-CCTGTGGGTTGCTAGCAGCTCAG--CTGCGCAAGGAAAACGTATTC----TGAAGAAC
H -1701 AGCATCTC-TGACTCAGTCTGTCCCCTGGAAGGCTGGCAGCTCAGCAAGCACAGAAG-------TCTCTCCAGAAGA C
P -1735 AGCACTTC-TGACTCAGTCCATTCCCCTGGAGGCTGGCAACTCAGAACTGGGCACAGAAAAACTCTCCCTCTGGAGGATG
*0 ... SeSOOSSO. .... SO0...SS 9.*... .
M -2089 GA-GG-TCACCTGCCTACCCAAAGCTGGGTATTCAATGTGTACTTTCCTATCCAG -AGGTTGGCATTCTGGGTGCCACT
H -1631 AGTGGGTCACCTGCCTCCCAAAAGCTGAAAGGCTAACTTGTACTTTCCCCAGCAGGCAGC-TGGCATCCTGA--GCCCTC
P -1656 AT-GGGTCACCTGCCCTCCAA--GCTGGATGGTTAATTTGTACTTTCCCAGGCAG--AGGCTGTCATCCTAAGAGCTCTG
Se.. . See.Be...** *000 . OS. .@eSOO . eee* S.. .e.**@* *
M -2014 GGCTGGGGTAAAGTCAAGCAG--CCTCCTCCTTCCTACCTCCTGG-CATTCTTTTCCAAGGTCCA
H -1554 GGCTGGGGCAGAG-CAAAGGAGCCTTCCTCCTTCCTACCTTCCTGGCACTCTCCCTGCCTTCCTT
P -1581 G-CTGGAGTACAA-CAAAGAGGCTTTCCTTCTTCCTGCCATCCTGGCACTCTCCTCCCTGCCCAC
5*5oSS* .0.....e *ee.*Bee..... e....... *e*e*OS. @-*.S-..................-@@.@ .........*
Figure 2. Region A sequence alignment between mouse, human and pig uPA promoters. Sequences for the mouse and pig uPA promoters were aligned with the
human uPA sequence (4). Sequence identity between any two of the three sequences is marked by (.) and sequence identity between all of the three sequences
is marked by (s). Consensus transcription factor binding sites are marked, and discussed in the text.
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Culture Collection and was tested free of mycoplasma.
Recombinant bacterial human macrophage colony-stimulating
factor (CSF-1) was a generous gift from Cetus Corporation(Emeryville, Ca.). Phorbol myristate acetate and dexamethasone
were obtained from Sigma (St. Louis, Mo.). Concentrated stocks
in dimethyl sulphoxide were stored frozen in aliquots and diluted
in complete medium immediately prior to use.
RESULTS
Sequence alignments
We have sequenced the mouse urokinase promoter to -6.6 kb
and the pig promoter to -4.6 kb. The former extends the mouse
genomic sequence 3.5 kb upstream from the sequence described
by Degen et al. (6) and R0rth et al. (9). The two sequences have
been deposited in EMBL Data Library (Accession Number: )
and may be obtained from us. A single variation was found
between our mouse uPA sequence and the sequence of Degen
et al. (6), an A not G at -2137, however variations were found
at five positions with the sequence of R0rth et al. (9); our
sequence contained an additional A inserted at -3176, an
additional C inserted at
-2989, no G present at -2956, a G
not a C at -2194 and a C not a G at -2192.
Figure 1 shows a Pustell DNA matrix comparison (25) of the
mouse and pig uPA promoter sequences. There is a 660 bp region
of sequence conservation between the two species from -2626
to -1970 in the mouse. This region also resembles part of the
human uPA flanking sequence and an alignment of the sequences
from the three species is shown in Figure 2.. We will refer to
this segment of the promoter as Region A.
Overall, 55% of the base pairs in Region A are conserved
across all three species, and > 80% are conserved between any
two species. In the central block of 250 base pairs, the homology
is even greater (74% in all three species, >95% in any two
compared). The total area of conservation covers both the
enhancer and suppressor regions described previously in studies
of transient expression in human tumour cells and mouse
keratinocytes (4, 9).
On the boundary of Region A there is an Alu-like repeat
sequence in the human promoter which extends to the boundary
of the published sequence (4). In the same relative position, there
is shift in the alignment between the mouse and pig sequences.
Approximately 1.5kb in the mouse, and 400bp in the pig,
upstream from this point there is a second block of sequence
similarity between the two species (Region B) extending for
around 400 bp (Figure 3). Region B is followed by a third block
of homology (Region C; Figure 4), which is almost continuous
in the pig promoter, but separated by a 400bp segment containing
B 1 repeats in the mouse (6). These repeats were assigned by
comparison with the consensus B 1 sequence described by Kalb
et al. (26) and the consensus B2 repeat sequence described by
Krayev et al. (27). Regions A, B and C in the mouse sequence
were scanned for known transcription factor binding sites using
IBI MacVector Version 3.5 software, and a library of sites
supplied with the package. Relevant sites are annotated on Figs
2,3 and 4, and discussed elsewhere.
Transient expression of reporter constructs in RAW264 cells
A series of deletion constructs of the mouse and pig uPA
promoters linked to the chloramphenicol acetyl-transferase (CAT)
gene were prepared as shown in Figure 6a. These deletions aredesigned to successively remove Regions A, B and C. The
-4156 OACAAAAGAOCCCCTCCACTAOTCTATGTCAGCACACOCO AGOTCTGCTCTCC
0 * * * e* * 0 *00 * * 0 * * * *0 * ** * * *e * *
2959 GAAGCAAOGCCCTCCCTATTAOTCTCCATTGCCACATCOAACTCOGGAGOTTTO0ACTOC
OCT
-4096 TOAGATACAAAAGCCACTT
.------.----------- 1I33333GAAAAIA0* 00* * ** * * * . ....-* OFM*W-
- 2899 TOAGACACAOAGOCOGGAGOCTOGTOOTTTTACTCTOAGCOTCAGOOOCAGAATOAAATC
OCT
4054 AT TOCTTTCTTATTTATCACTCTCAACAGAAACTTCAOCCAOTTTAQACCACA***^ ~ * 0* 0** *0ee 0*0* 00000o *00** *0 *000 e
-2839 ACACATATTCAGTTCCTTATTT-TCACATTCAACAGAAATTTCAOT-A0CCOTOACCCCC
NF%B AP2 OCT
-3 994 A CGTOA^ATTr.AGOCA^^Al3 AC4330G OTTOOCATCCTAAGAAA
2781 AA0TTTOGTCCT^AAACTCA00CAACA0ACTAACTCATATTATAOCCOGGGOCCTCAC:A
*3934 AAAGAAGAAGAAAAAAA---- TOT AP3/6P2 ATAGATAGAAOA
2721 AOCTCAGAOCCCACAOTCCTAGGAOTTTCTAOAAG^OGATCTCCAAAQTCTCCTTO ----
3679 CTT0AGOCAAAC- ACTGGOCTOGAATATTTTATACCACCT0CCTGAOTATCTTAOTTAAC
2665 ---- TOGOOCTCCCCCTGAOCTOGAACATCTACATCATCTOGCCOTTTTCTTCATAOCCT
Figure 3. Region B sequence alignment between mouse (upper) and pig (lower)
uPA promoters, annotated as in Fig 2. Consensus transcription factor binding
sites are marked, and discussed in the text.
reporter constructs were transfected into the mouse macrophage
cell line RAW264 using electroporation. Primary macrophages
and macrophage cell-lines are difficult to transfect with
conventional chemical methods (28), but a modified
electroporation procedure gave highly reproducible results with
RAW264 cells. In a series of experiments using a human ,B-actin
promoter-CAT expression plasmid (29; a gift from Dr. P.
Gunning) as a test system, optimum CAT expression was
dependent on several factors (manuscript in preparation). The
use of complete medium (i.e. including serum) was more effective
than simpler media such as HEPES-buffered saline. CAT
expression was plasmid concentration-dependent over a broad
range. There was an electroporation voltage optimum around 750
V/cm at 960 ftF and a temperature optimum of 250C.
The RAW264 cell line is a product of Abelson leukaemia virus
transformation of mouse spleen (16) and constittively synthesizes
uPA mRNA (KS, data not shown). Results in Figure. Sa show
that removal of Region C from the mouse promoter caused a
3-5 fold reduction ofCAT expression in transiently-transfected
RAW264 cells. Further deletion of Regions B and A caused
successive reductions in promoter activity of 2-3 fold.
The pig promoter constructs were up to 50-fold more active
than the mouse constructs (note the different vertical scale in
Figure Sb). In each of three experiments, each successive deletion
reduced promoter activity. Because the pig deletions are actually
in the middle of Regions B and C they cannot be directly
compared with the mouse constructs. The data do, however,
support the conclusion that Regions B and C play a role in uPA
promoter activity in RAW264 cells. The location of the conserved
regions and the positions of the deletion constructs are
summarized in Figure Sc.
The mouse promoter constructs used in Figure 5a differ from
those used by R0rth et al. (9), and from the pig promoter
constructs, in lacking 5' untranslated sequences. The CAT gene
was fused to the Sac I site at +8 relative to the transcription
start site, whereas R0rth et al. (9) used the Xba I site at +398,
immediately 5' of the start of translation. The same conserved
Xba I site was used in the generation of the pig CAT construct.
Thus, the difference in the level of expression between mouse
and pig constructs in Figure 5 could be attributed to elements
present between the transcription and translation start sites,
between +8 and +398 in the mouse sequence. To examine this
possibility a mouse reporter construct containing the additional
-5768 GTATTCGTGTAGOTAATACATTTCTQCCTTACTGTGTTTGAATTAGQGACAAAAGAAATTTQGCCAAGGCTCAAGAATTTCATG
*** 0 * *** ** * 00 **** ******** * * **** ** ******e* ******
-4195 GTAATAAGTTCTGOTCTTAGGAGGTTACCAA.GTTTAGATTAGGGAGACAOGAAATTTGCCAAGGCTCAAAATATTCATG
-5683 CAGAAGTCTGAGATAATTGGTTTGAGTATA- - TACAATCAGA- TCAQCAGAGTCATG ----- AAATAACAAGGACGTTTAGAG
**** ******* 0 0 *** 0** ** ** 0 ** *** * 0 * ** ** *
-4115 CAGAGGTCTGAQCTTACTGOCTTGOGTGGGOCTAQGAATTGAGCCAGAGATGACGAGnCAGAAAATGACGAGAAAGAGTAGGG-G
API
-5606 11AG-CCGAACATAAACGAGCCAAGTTGACCTGTGCGTTTCTGTGTTATTGACGACATCATGTAACCTCAGGGTTCAGCCCTT
00**** * * * * 0 * **** *** * *** ** 0 ****** * *00**** **** ****
-4031 TCATASGCTGGAGCTGGAGGTCCAACTTGOC -------- TTCACTGATCCTGACGAAGAG- TATAACCTC-GGGTGGCCCCCT-
AP2
-5522 GAQTGCTTTGCTTTCCTAGAGTAAGGOCACAAATATGTGGCTTCCCTCC A TCCACAC TTAGGGACCCACTA
* * 0*0000***** *0000000 *** 0*00*00****** * *** ..... 00* . .00 0.0* *
-3957 GGCT-CTTTQCTTTCCATQAGTAAGOAAOCAAGTATGTOQCTTCCCCCG-CCCTATTCTTTCCAC-GGCC- T-GGG-CCCAGCA
AP2 AP2
-5442 GCC CI TCC TAOTT --------------------- TTCACCTTGACCACT
**i***i******* * s *t * ***.w ****** ** *0 *
-3879 GCCCCAGCACCTCCCCTATCATGTTACAGGCCCCAAACGTQOCTTCCAGTGCCTACTGTGAAATAGGATCTTCACTGTG- -CATT
AP2
-5381 AAGCACACAOTAGGACAGOO- -AGGGGCCTTAGACTCAAGGATTTAAGATGATCAA- TTCCATGGTCTGTfTCCCA-A C
* * * 0*00* * * 0*** *** ** *** * ** *0 * ** * * ****** ******
-3796 A------ CACATG- -CAGGAGAAATAGTCCTTGOACCCATGGAAGCTATGTGACCAGCATTCACTGCCCCCTTCCCAGAACTGC
API
-5300 T- -GOGATCTGTTTOCCAATATGTTAGGAAOGAGTTTTAAAAAGATT1TCATACT0 A TC --CAGATAAGGGQGG-G
3719 A-A--A- ---ATAT -TA -AT ---T ---AAA----A-A--GTGC G -3 71 G^AGGATCTATAT - TACCATGTGTG1AGGAAG - - -- AGAQAGATTTC - -- GTGCCACG -GACAAC TGGAGAGGAGGAGGGGA
AP3 AP2 AP2
5220GA13T§IQWAGGAIA GAiFNACAST OTCTTTECCATCTQCGATTGTAGGAACTGTGGGCCAAGGA
AAA*AQA** .i ** ******* *** ****
3 62 4 GAGTGGATCAGBACTAC -AGQATGAGCAQCACATG -- -- -- -- -- - -- CAGCTGOCCQG3TTGCTGGGAACTGC TGGCTGAGGA
AP2 AP2
-5135 AACTGAATCCTGCA-GCATATT EEWTTTTTGOACCAAAATQ3GACA ----- AGCAAA
******* 7************* * * IROWOOM0*0**OW* ** *** *** * * ** ** **
-3572 CACAGTATCCTCACTTAACTGAATCCTGAATOGACTCTCOAGAATGACCTGGACTTCTQGGCCAGGACAGCCATGGTTAGGAAG
-5056 GQA-GGGAAGCACTTTAGATAGGAATTGCAGTTTACAAAA---- TCCATCTTTCTGTTTTTAGCACCTGGAACTATACCGGCACA
* * *0 0 ***** $0 *0*00** ******* * 0** ** *** 0 ** ** * ***** * ** * **
-3486 GCAAOGCAGGCACTCGAGOTASAATTATAGTTTACAAACAAGOTTCATTCTTGTQTCTCTACCATGTAGAACTGTGCCTG-ACG
OCT
-4978 CATAGTAGTCCTTTCACTA-CT 7 TQ23- A,VATQ ACTTTTCC .--------- CAC
-3402 CACAGGAQGCCCATGACGAACACTGGGTGAATGAATAAAGGAATAAATGAATGATTTCACACGCATGATCTCAATGCATGATCAC
CRE SRE(S-ACTINI
4905 AT WQ**TCAlC SjCTCA&PWT-
* * **** wooowe*e
- 331 7 A -ACGCATGATCTCAT TCAATCTGCACAGTGA
OCT
-OACCAGG ------CTGTTTC A ACAACCAAAGTCA
*O A* CT**TT ***** *G'AGGGCAQGTAGWCATTGCGTCTTTTTCAGATG -AGAACAGAGACCA
-4831 AAAGAOTTAAGTGCCTTG ----- TTTAAAGTC ---------------------- ATTCTA-CTACAATACCATACTGAA- TGTTC
* 00 *00**** 0*0* 0* * 0 * *** * * * * ***** * ** ***
-3234 AGAGGATTAAGTGTCTTGCCAATTTGOATGACCTGACCTGTGCTAGACTCCACATTTTCTCCATAGTACCAAGTTCAACA- TTC
API AP31icS API
-4775 TTAGTATAGCAACCCAAGAATATATCCCAO]E i36CA -TTTT9ACCCAG 5AATAQtAATG-t
** ***$***#* **** # * * **** o** * VW6"s*** ** s * **V-WWVW******* rFTW- f'
-3150 TTOGTATAGCAGCCCAGGGAAACATCCTOTGACTCGATGT-GAACTTCCCTTTAGOTACTT-CTGGTCAGAAAATAGCCCTTCAA
-4692 AGGAT TMCACAGGCTTOTAATCCTAGCACTTAGGAAGTGCAGACTACAGTGAGTTTAAGGTCAGCCTGGGCTACAT
-3067 TGCCCTTCAATGGCCCAGTTTCCTG-AACACAGTTTCGGGTCAATTTGACATCCTGOTCCTCCTTGCACGCTTGGTATCTGC
Figure 4. Region C sequence alignment between mouse (upper) and pig (lower)
uPA promoters, annotated as in Fig 2. The sequences of the mouse and pig uPA
promoters are aligned. Consensus transcription factor binding sites are marked,
and discussed in the text.
5' non-coding sequences was prepared. The presence of this
region caused a 5-10 fold increase in CAT expression compared
to the shorter mouse construct, but a residual 3-5 fold difference
between the pig and mouse promoters remained (Figure 6a).
The data of R0rth et al. (9) emphasised the role of a perfectly
conserved sequence, (5'-AGGAGGAAATGAGGTCA-3') in
Region A (see Fig 2, -2440 in the mouse) in both constitutive
and growth factor-inducible promoter activity in keratinocytes.
This sequence was deleted from the full length pig promoter using
the polymerase chain reaction (see Materials and Methods) and
the resulting deletion tested for activity. As seen in Fig 6b, the
deleted construct had 10-fold reduced activity compared to the
control.
Electrophoretic Mobility Shift Analysis
R0rth et al. (9) referred to the sequence above as a
PEA3/API-like element. Macrophages have been shown to
express a transcription factor, PU-1, which is a member of the
ets family and binds to the core recognition sequence 5'-GAGG-
AA-3' (20) found in this element. Potential PU-1 sites are even
more numerous in distal parts of the promoter. From -4970
to -5310 in mouse Region C (Figure 4), there are four
polypurine tracts in which the core PU-1 (ets family) sequence
(5'-GGAA-3') is repeated six times. Between these tracts are
several polypyrimidines, with the inverse ets sequence (5'-TT-
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Figure 5. Expression of mouse and pig uPA promoter-CAT reporter gene
constructs in transiently transfected RAW264 cells. A. CAT activities of RAW264
cells transfected with 20 yg of the mouse uPA promoter construct, pUPACAT
(-6616) and molar equivalents of deletion constructs. Error bars show the range
of values obtained in four independent experiments (each containing duplicate
transfections). B. CAT activities of RAW264 cells transfected with 10 g of of
the pig uPA promoter construct, pCAT4660 and molar equivalents of deletion
constructs. Error bars show the range of values obtained in three independent
experiments (each containing duplicate transfections). In each experiment CAT
activity dropped progessively with the first three deletions. C. Summary of mouse
and pig reporter constructs. pUPACAT and mouse deletion constructs (Figure 5a)
do not contain the conserved 5' untranslated region. The 5' untranslated region.is
present in pUPACAT2 (Figure 7).
CC-3') repeated 4 times. These 300bp of mouse sequence are
65% conserved in the pig. Interestingly, of 77 base changes
between the two species, 47 involve purine-purine or pyrimidine-
pyrimidine substitutions suggesting there are constraints on base
substitutions. In Region B (Figure 3) there are also several
conserved purine strings and the ets core sequence is present six
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Figure 6. Expression of mouse and pig uPA promoter-CAT reporter gene
constructs in transiently transfected RAW264 cells. A: Relative CAT activities
of RAW264 cells transfected with 20 Ag of pUPACAT and molar equivalents
of pUPACAT2 and pCAT4660. Results were normalized to pCAT4660. Error
bars show the range of values obtained in three experiments. B: Relative CAT
activities of RAW264 cells transfected with 20 itg of pCAT4660 or pAPEA3/APl
CAT4660. Results are normalised to pCAT4660. Error bars show the range of
values obtained in 3 experiments.
times. For this reason, we performed electrophoretic mobility
shift analysis of the expression of nuclear proteins in RAW264
cells that bind to the PEA3/API element (Fig 7a). RAW264 cells
contain two prominent nuclear activities that bound to a PU-1
oligonucleotide derived from the SV-40 early enhancer (20). The
faster migrating.and more abundant complex contains a protein
of approximately 32kD as determined by UV cross-linking to
the radiolabelled probe and comparison to molecular weight
standards (T. Dunn et al.; submitted for publication). The
estimated Mr is consistent with its identity as PU-1 monomer
(20). The nature of the slower migrating complex is not known,
but we have shown elsewhere that it is also macrophage-restricted
(T. Dunn et al.; submitted for publication). When the same
extracts were incubated with an oligonucleotide spanning the
PEA3/API-like region, no complex co-migrating with either of
the PUI bands could be seen. Instead, a single prominent band
was evident. When cross-competition experiments were
performed, the PU-1 oligonucleotide did not compete with the
PEA3/AP1 oligonucleotide, nor was there any competition in
the reverse direction (Figs 8a and 8b). We have reported
elsewhere (T. Dunn et al.; submitted ) that RAW264 contains
multiple nuclear proteins (including PU-1) that bind to the itB
sequence of the immunoglobulin heavy chain enhancer (21). This
sequence also contains a tandem repeat of the 5'-GGAA-3' ets
family core recognition sequence. Hence, we performed
competition experiments with the yB oligonucleotide, but again
there was no competition for binding to the PEA3/AP1
oligonucleotide (Figs 8a and 8b). Cold PEA3/AP1 did compete
for binding of the labelled probe, although even at 100-fold excess
Figure 7. Electrophoretic mobility shift analysis of nuclear proteins expressed
in RAW264 cells under various conditions. A) Nuclear proteins were incubated
with the radiolabelled oligonucleotides shown (see Methods) and separated on
8% PAGE. The labelled probe has been run off to achieve greater resolution.
Each probe was added at the same concentration and specific activity. B) Nuclear
proteins were extracted from RAW264 cells treated for 2hr with 500 ng/ml PMA
or for 6hrs with dexamethasone (10-7 M), dexamethasone + PMA, or CSF-1
(104 U/ml) and incubated with radiolabelled API oligonucleotide prior to
separation on 6% PAGE. C) The same nuclear extracts as shown in Panel B
were incubated with radiolabelled AP-2-like oligonucleotide from the uPA promoter
(see Methods) and separated on 6% PAGE. D) The sarm nuclear extracts as
shown in Panel B were incubated with radiolabelled xB oligonucleotide (see
Methods) and separated on 6% PAGE.
there was still some residual binding (Fig 8a). The PEA3/APl
complex was resolved into two bands by running the complex
to the bottom of a 6% polyacrylamide gel, but both bands had
the same apparent binding affinity (not shown). Note that there
is also some residual binding of the PU-1 oligonucleotide at
100-fold cold probe excess (Fig 8b). In summary, RAW264 cells
contain a nuclear protein (s) that binds to the PEA3/AP1 element
and is probably not an ets family member. In the upstream regions
there are no sequences that are a better match for the PU-I
oligonucleotide than the PEA3/API element. Although we have
not tested each of them independently, we feel it is unlikely that
any of them contributes to the expression of the gene in RAW264
cells.
This conclusion focuses attention upon the API-like component
of the PEA3/AP1 element. Since the element has been implicated
in growth factor responses in keratinocytes (9) we investigated
whether agonists such as macrophage-specific growth factor,
CSF-1, or phorbol esters, and an antagonist of of their action,
glucorticoid, caused any change in expression of the nuclear
protein that bound to the PEA3/AP1 region. No change was seen,
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Figure 8. Electrophoretic mobility shift analysis of the binding specificity of nuclear
Proteins Expressed in RAW264 cells. Panel A: Nuclear extracts from RAW264
cells were incubated with radiolabelled PEA3/AP1 oligonucleotide (see Methods)
in the presence of the indicated excess of cold PU. 1, tiB or homologous probe
and separated on 8% PAGE. Panel B: An identical experiment to Panel A, run
back-to-back on the same apparatus, except that labelled PU. 1 .oligonucleotide
was used.
and representative data is shown in Fig 7a, for PMA. Note in
Fig 7a, that RAW264 cells did express multiple nuclear proteins
that bound a consensus API oligonucleotide, but these did not
comigrate with the complex formed with the PEA3/API element.
The API-binding proteins of RAW264 cells are resolved more
completely on 6% PAGE in Fig 7b. Untreated cells contain one
well-defined complex, and two broad smears of slower-migrating
binding activity, all of which can be competed by specific
oligonucleotide (not shown). Unlike the PEA3/AP1 binding
activity, API binding proteins were acutely regulated. PMA
caused a substantial increase in expression of all of the
components of the two smears that bound to the consensus API
oligonucleotide, and steroid almost abolished the expression of
all of these complexes (Fig 7b). The control for Fig 7b is provided
in Figs 7a, c and d, which shows that none of these treatments
altered expression of nuclear proteins that bound other
oligonucleotides. The pattern of induction by CSF-1 was more
puzzling, since only the faster-migrating smear was increased,
whereas the more defined band actually decreased (Fig 7b). The
conclusion is that the supposed AP1-like sequence (5'-TGAGGT-
CA-3') does not bind API complexes generated in RAW264
cells. On the other hand, the uPA promoter does contain API
consensus sites; three in Region A, one in Region B and three
in Region C (Figs 2,3 and 4).
In Region A, B and C we were struck by the presence in highly
conserved regions of a motif containing repeats of the sequence
5'-CAGC-3', strongly reminiscent of the AP-2 region of the
SV-40 enhancer (30). One of these occurs around -2410 in the
mouse promoter, in which the sequence is perfectly conserved
between the three species for 29bp. We prepared an
oligonucleotide covering this conserved region, and performed
electrophoretic mobility shift assays as shown in Fig 7c. Two
abundant, and prominent bands were observed in RAW264 cells,
neither of which was altered in its abundance by CSF-1, PMA
or steroid.
Finally, Region A contains a highly conserved xB consensus
element, 5'-GGGAATTTCC-3' at -2340 in the mouse. NFxB
has been implicated in the macrophage-specific expression of the
human immunodeficiency virus LTR (18). RAW264 cells con-
tained only a single band that bound to an NFxB oligonucleotide
based on the human immunodeficiency virus long terminal repeat.
This band is also seen with a mutant oligonucleotide in which
the G triplet is mutated to CTC (see 18) (data not shown). The
abundance of this band was not changed by any of the treatments
(Fig 7d). Slower migrating 'activated forms' (32,33) could not
be detected in RAW264 cells. Such complexes were readily
detectable in RAW264 cells that had been exposed to bacterial
lipopolysaccharide (data not shown).
DISCUSSION
This paper contains the first study of the transcriptional regulation
of the uPA gene in macrophages using reporter gene constructs.
We have presented sequence information comparing the pig and
mouse uPA promoters, and have used transient transfection to
confirm the biological importance of the regions of sequence
homology between the two species. The sequence conservation
between human and mouse in what we have called Region A
was noted by Rorth et al. (9). Additional comparison of the pig
sequence in Fig 2 highlights a block of around 250 bp that is
most highly conserved. The homology blocks referred to as
Regions B and C lie 5' to the sequence reported by R0rth et al.
(9). They lack substantial homology with Region A, as evidenced
by the virtual absence of secondary alignments on the Pustell
matrix (Figure 1). Surprisingly, the complex cyclic AMP-
response element in the pig promoter, between -3415 and
-3340 in Region C (Fig 4), identified by functional studies in
pig LLC-PK1 cells (19) is very poorly conserved in the mouse
sequence. There is conserved consensus cyclic AMP response
element (5'-TGATCTCA-3') immediately downstream (at -3310
in the pig; -4998 in the mouse). There could be a genuine
difference in cyclic AMP responsiveness between the two species
or between cell types, since uPA expression in murine
macrophages is actually reduced by cyclic AMP agonists (11).
The combined PEA-3/AP-1 site (5'-AGGAAATGAGGT-
CA-3') within Region A has been implicated in phorbol
ester/EGF induction of uPA in mouse keratinocytes (9) and was
known to be present in the human gene. This sequence is almost
perfectly conserved between mouse, pig and human (Figure 2).
Deletion of this element from a 4.6 kb pig promoter caused a
10-fold reduction in expression of the reporter gene construct
in RAW264 cells (Fig 6) Electrophoretic mobility shift analysis
revealed that the cells contained nuclear protein(s) that formed
a complex with the deleted DNA sequence. This complex is a
candidate as a transcriptional regulator responsible, in part, for
constitutive expression of the gene. Despite the presence in the
PEA3/AP1 element of the core recognition sequence, 5'-GAGG-
AA-3', this complex did not co-migrate with either complex
formed with the recognition sequence for the macrophage-specific
transcription factor PU-1, a sequence has been recognised as
being essential for the expression in macrophages of a mutant
SV40 virus lacking the 72 bp repeat enhancer (20). Further,
in cross competition experiments, no competition was seen
between the PU-1 and uPA sequences for binding to either of
the complexes. Since the 14B oligonucleotide, which also contains
the polypurine string, did not compete for binding to the
PEA3/API element, we consider it unlikely that an ets family
protein is involved in the complex.
The data in Fig 7 show that the complex that binds the
PEA3/API element in RAW264 cells is also quite distinct from
those that bind an API oligonucleotide. As noted by R0rth et
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al. (9) the API-like sequence of the uPA enhancer, 5'-TGAGGT-
CA-3' is also closely related to a cyclic AMP-response element,
5'-TCACGTCA-3'. There is evidence that c-jun proteins, which
form part of the AP-l dimer with c-fos, can also form dimers
with cyclic AMP response element binding (CREB) proteins (9).
Given the constitutive expression of multiple AP-1 binding
activities in RAW264 cells, we can presume that jun proteins
are expressed. The involvement ofjun proteins in the complex
that bind the sequence TGAGGTCA therefore seems plausible,
but a definitive conclusion awaits immunological
characterisation.Whatever the nature of these two complexes, it
should be noted that in keratinocytes proteins that bound to this
sequence were induced by phorbol ester and growth factor (9),
whereas in RAW264 cells they are present constitutively and
completely unaffected by agonists.
The data in Fig 7d suggest, in contradiction to earlier claims
that macrophage express activated NFxB (18), RAW264 cells
contain only the so-called constitutive xB-binding protein,
expression of which is not correlated with enhancer activity.
Hence, the conserved xB element in Region A is unlikely to play
a role in constitutive expression of uPA in RAW264 cells.
Surprisingly, phorbol ester had no effect on the expression of
activated forms of NFxB where, in the same extracts, there was
clear induction of API binding proteins (Fig 7b). The p50 and
p65 subunits of NFxB are found in most cell types complexed
to a cytoplamic inhibitor protein, IxB (31). The complex is
dissociated upon treatment of the cells with phorbol esters, an
effect that can by mimicked by direct phosphorylation with protein
kinase C (32). In primary macrophages and macrophage cell lines
including RAW264, NFxB is activated by bacterial
lipopolysaccharide (33, and unpublished) which does not induce
uPA. Nor does it have any effect on expression of uPA promoter-
reporter constructs in RAW264 cells (data not shown). For these
reasons we think it unlikely that the xB consensus sequence in
Region A functions as an NFxB-dependent enhancer element in
macrophages. The observation leaves open the question of why
NFxB is not activated by PMA in RAW264 cells. We have
confirmed this finding in primary macrophages (unpublished)
raising the possibility that the activity of this factor is regulated
differently in this cell type.
Despite the presence of multiple presumptive binding sites for
transcription factors shown in Figs 7 and 8 , and evidence from
the deletion study that at least one of their recognition sequences
was essential for maximal gene expression, truncated promoter
constructs containing Region A alone were poorly active in
RAW264 cells. Maximal activity required both Region B and
Region C (deleted progressively by the Hind HI and EcoR V
deletions respectively in Fig 5). Regions B and C contain
additional consensus phorbol ester response elements, including
a conserved API consensus site at -4750, that would presumably
be recognised by the AP1 that is constitutively expressed in
RAW264 cells (Fig 4). Regions B and C also contain multiple
repeats of AP2-like sequences, which can also be recognised by
binding activities expressed constitutively in RAW264 cells (Fig
7c). In fact, the AP2-like sequences around -4720 (Region C)
in the mouse is immediately adjacent to an AP3-like sequence
(5'-GGAAATTCC-3') at -4740, which is, in turn, next to the
conserved API site at -4750. The overall structure is strikingly
reminiscent of the SV-40 72 bp repeat (30). One other feature
of Region C that may be relevant to expression of uPA is the
presence of a serum-response element or CArG box, the 10 bp
palindrome 5'-CCTTTAAAGG-3', from -4699 to -4690 in
the mouse. This is conserved with one mismatch in the pig and
flanked on the 5' side by a further 12 bp of perfectly aligned
sequence (Fig 4). In the pig, the CArG box motif is reiterated
immediately downstream. CArG boxes have been implicated in
both growth factor responses and tissue-specific gene expression
(34). The CArG box is not the only sequence element implicated
in serum-responsiveness. Immediately upstream at -4880 in the
mouse, there is a well-conserved sequence that resembles the
serum-responsive regions of the (3-actin promoter (35).
The last element that is highlighted in the alignments shown
in Figs 2,3 and 4 is the binding site for the octamer family of
transcription factors, 5'-ATGCAAAT-3' (36), recognised by the
ubiquitous transcription factor Oct-1. The sequence at -4060
in the mouse (region B) is the 5'-TAATGARAT-3' sequence
found in the Herpes simplex virus immediate early enhancer,
which is known to bind Oct-I (37). Macrophages, including
RAW264 cells, contain both Oct-I and a tissue-specific octamer
binding protein, Oct-2 (36, T. Dunn et al.; submitted for
publication).
The data in Fig 7 demonstrate that thetranscribed 5' non-coding
region plays a role in uPA gene expression. Sequences
immediately downstream of the transcription start site have been
shown to affect expression of transfected constructs in other
systems (38), due to the presence of elements that control
transcription initiation (39), transcription elongation (40) and
mRNA stability or processing (41,42). There are also examples
of enhancers within introns, for example in the ,B-actin and
adenosine deaminase genes (35, 43). In other cases, the
requirement seems to be for a splicing event, and the sequence
of the intron upstream of the translation start site is irrelevant
(34). Our data do not distinguish between these potential
mechanisms.
Even when transcribed 5' non-coding sequences were included
in both constructs, the pig promoter construct was more active
in RAW264 cells than the mouse promoter (Fig 7). From the
data in Fig 6, a pig construct that lacks Regions A, B and C
(-1767) is 50-fold more active than an equivalent mouse
construct (-2186). Assuming that the transcribed 5' non-coding
region acts independently, this observation suggests there is some
functional difference in the proximal promoter, a region that is
poorly conserved between the two species (Fig 1). In the pig,
the proximal promoter consists of a TATA box, three GC-rich
SpI-binding sites and a CCAAT box. The CCAAT box and two
of the SpI sites are displaced to -450 bp in the mouse promoter
by an intervening polypurine repeat starting at -60 bp. In
previous studies using pig LLC-PKI cells, removal of the CC-
AAT box and the two more distal Spl sites from the pig uPA
promoter greatly reduced basal activity in an in vitro transcription
assay and abolished inducibility by cyclic AMP (14). Thus, the
relatively low activity of the mouse promoter could be caused
by the separation of these proximal elements.
The alignment between the mouse and pig sequences ceases
around -5.8 kb and -4.2 kb respectively. The extreme 5' end
of the mouse promoter sequence contains two head to head B2
type repeats based on the consensus sequence for similar elements
in mouse uPA introns (6) suggesting that there is another shift
in the sequence alignment between the two species at this point.
This raises the possibility that more blocks of sequence
conservation exist further upstream. As noted in the introduction,
the introns of uPA genes are almost as highly conserved between
species as the exons. The sequence data we have presented show
that, after a gap of around 2 kb immediately upstream of the
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transcription start site, sequence conservation reappears and
extends for at least a further 2.5 kb (interrupted by repeat elements
in the mouse). One obvious possibility is that there is another
gene in this upstream region. We used the program MacVector
to perform an analysis of open reading frames (ORFs) in the
mouse promoter. The analysis reveals the existence of prolonged
( > 200 bp) continuous coding capacity that correlates well with
the regions of sequence conservation with the pig gene (which
also contains prolonged ORFs on the reverse strand). Region B
contains consensus TATA boxes in both species (marked on Fig
3) although these do not align. A search for consensus splice
donor acceptor sites did not reveal convincing intron-exon
boundaries that are conserved between mouse and pig, and we
could not detect any transcripts that hybridised with uPA promoter
in RAW264 cells (unpublished). Furthermore, a search of the
GenBank database failed to reveal any homology between the
uPA promoter and any known coding sequence, and no mouse
ORF could be aligned with a pig ORF at the protein level. These
analyses do not eliminate the possibility that Regions B and C
contain 5' non-coding or leader sequences of another gene
extending further upstream.
In summary, our analysis has revealed that the constitutive
activity of the uPA promoter in RAW264 cells cannot be ascribed
to a single tissue-specific element, but rather results from an
interaction between multiple elements spread over at least 6.6
kb of 5' flanking sequence in the mouse and 4.6 kb in the pig.
These elements are separated from the transcription start site by
a long stretch of unconserved DNA that might serve a spacer
function, diluting the effect of a powerful enhancer. The existence
of such a large and complex promoter may be a reflection of
the multiples roles of uPA in development, and its ability to
respond to numerous different extemal stimuli in different cell
types.
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